resources

Sudeep Pharma Ltd.

NSE: SUDEEPPHRM

BSE: 544619

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

808.45+8.2 (+1.02%)

9 Jul, 3:29 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sudeep Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2025	2026
Annual Reports	—	—
Quarterly Results	Sept Dec	Mar
Conference Calls	25Dec	12Feb 28May
Presentations	21Dec	7Feb 21May

Corporate Announcements and Regulatory Filings

Sudeep Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Change in Management26 Jun 2026
Announcement under Regulation 30 (LODR)-Change in Management
This is to inform that the Board of Directors at their meeting held on 26th June 2026 has appointed Mr. Milin Mehta as an Additional Director of the Company with immediate effect.
Outcome without intimation26 Jun 2026
Board Meeting Outcome for Appointment Of Mr. Milin Mehta As An Additional Director (Non-Executive & Non-Independent)
This is to inform that, the Board has appointed Mr. Milin Mehta as an Additional Director (Non-Executive & Non-Independent) w.e.f. 26.06.2026.
Closure of Trading Window25 Jun 2026
Closure of Trading Window
Intimation for Closure of Trading Window w.e.f. 1St July 2026 for Adoption of un-audited Financial Results for the Quarter ended 30th June 2026.
Reg.24(A)-Annual Secretarial Compliance27 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for FY 2025-26
Analyst / Investor Meet23 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, we herewith submit the participation of Company Officials ....
Analyst / Investor Meet22 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Submission of Audio Recording of Investor''s Call/Meet held on 22nd May 2026 at 11:00 a.m.
Newspaper Publication22 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of the SEBI LODR Regulation, we hereby submit the copies of the extract of audited financials results of the Company for the 4th Quarter and year ended ....
Dividend Updates21 May 2026
Announcement under Regulation 30 (LODR)-Dividend Updates
This is to inform that the Board has recommended Rs. 1.50/-dividend per Equity Share for the Financial Year 2025-26
Outcome of Board Meeting21 May 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026
Outcome of Board Meeting held on 21st May 2026
Analyst / Investor Meet14 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (LODR)Regulations, 2015 the Analysts/Investors meet is Scheduled on Friday, 22nd May 2026 at 11:00 a.m. to discuss the operational & financial performance ....
Board Meeting14 May 2026
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarter And Year Ended 31St March 2026.
Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74 (5) of SEBI (DP) Regulations.
Closure of Trading Window26 Mar 2026
Closure of Trading Window
Intimation for Closure of Trading Window w.e.f. 1st April 2026
Analyst / Investor Meet17 Mar 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting ....
Analyst / Investor Meet9 Feb 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Submission of Audio Link for the call held on 9th February 2026
Analyst / Investor Meet9 Feb 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Submission of Audio Link for the Investors Call held on 9th February 2026
Analyst / Investor Meet7 Feb 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Re-schedule of Earnings Call with Analysts/Investors on 09th February 2026 at 11:00 a.m. all the investors are requested to take note of the same.
Newspaper Publication7 Feb 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of SEBI (LODR) please find attached newspaper publication for extract of un-audited financial results for the third quarter and nine months ended 31st December 2025.
Outcome of Board Meeting6 Feb 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026
Submission of Unaudited Standalone & Consolidated Financials as on third quarter and nine months ended 31st December 2025
Change in Management5 Feb 2026
Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to the Regulation 30 of SEBI (LODR) Regulation 2015 we hereby submit that Mr. John Garcia (VP - Sales & Supply Chain) of Sudeep Pharma USA Inc, designated as SMP, vide his letter ....

Frequently Asked Questions

Where can I download the annual report of Sudeep Pharma Ltd.?

Annual reports of Sudeep Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sudeep Pharma Ltd.?

Quarterly earnings results and presentations of Sudeep Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sudeep Pharma Ltd. publish earnings call transcripts?

Earnings call transcripts of Sudeep Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sudeep Pharma Ltd.?

Investor presentations and annual day presentations of Sudeep Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sudeep Pharma Ltd.?

Corporate announcements and regulatory filings of Sudeep Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sudeep Pharma Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sudeep Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sudeep Pharma Ltd.?

The ISIN (International Securities Identification Number) of Sudeep Pharma Ltd. is INE0QPI01025. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sudeep Pharma Ltd. listed?

Sudeep Pharma Ltd. is listed on NSE and BSE. The NSE symbol is SUDEEPPHRM and the BSE code is -.

Where can I find the shareholding pattern of Sudeep Pharma Ltd.?

The quarterly shareholding pattern of Sudeep Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sudeep Pharma Ltd. on Sharpely?

Share price data for Sudeep Pharma Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.